{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:57:02Z","timestamp":1774414622716,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870469"],"award-info":[{"award-number":["81870469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170699"],"award-info":[{"award-number":["82170699"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["WSN-010"],"award-info":[{"award-number":["WSN-010"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018592","name":"\u201c333 Project\u201d of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clim.2022.109211","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:03:25Z","timestamp":1671537805000},"page":"109211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Efficacy and safety of rituximab for primary nephrotic syndrome with acute kidney injury: A two-center prospective cohort study"],"prefix":"10.1016","volume":"246","author":[{"given":"Yili","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianqin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanggang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.109211_bb0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","article-title":"Evidence-based clinical practice guidelines for nephrotic syndrome 2014","volume":"3","author":"Nishi","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.clim.2022.109211_bb0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2215\/CJN.11200919","article-title":"Mortality and recovery associated with kidney failure due to acute kidney injury","volume":"7","author":"Shah","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2022.109211_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"1","author":"Fervenza","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109211_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s13730-015-0199-5","article-title":"Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury","volume":"1","author":"Ashikaga","year":"2016","journal-title":"CEN Case Rep."},{"key":"10.1016\/j.clim.2022.109211_bb0025","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"4","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.clim.2022.109211_bb0030","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/ndt\/gfw251","article-title":"Low-dose rituximab is poorly effective in patients with primary membranous nephropathy","volume":"10","author":"Moroni","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2022.109211_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ckj\/sfx105","article-title":"Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience","volume":"3","author":"Bagchi","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.clim.2022.109211_bb0040","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.kint.2020.12.029","article-title":"Personalized phospholipase A2 receptor antibody-driven rituximab treatment strategy in membranous nephropathy","volume":"4","author":"Delafosse","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2022.109211_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ckj\/sfx105","article-title":"Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience","volume":"3","author":"Bagchi","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.clim.2022.109211_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000493189","article-title":"Efficacy of semiannual single fixed low-dose rituximab therapy in steroid-dependent minimal change nephrotic syndrome: a case series","volume":"3","author":"Usui","year":"2018","journal-title":"Case Rep Nephrol Dial"},{"key":"10.1016\/j.clim.2022.109211_bb0055","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/ndt\/gfab037","article-title":"Rituximab in primary membranous nephropathy: a comparative study of three dosing regimens","volume":"36","author":"Ramachandran","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2022.109211_bb0060","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"8","author":"McLaughlin","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2022.109211_bb0065","article-title":"Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment","volume":"29","author":"Iwabuchi","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2022.109211_bb0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"4","author":"Ruggenenti","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2022.109211_bb0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","article-title":"Acute kidney injury complicating nephrotic syndrome of minimal change disease","volume":"5","author":"Meyrier","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2022.109211_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10157-020-01992-8","article-title":"Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome","volume":"3","author":"Nishide","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.clim.2022.109211_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.ajkd.2003.10.039","article-title":"ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane","volume":"3","author":"Vande","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clim.2022.109211_bb0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"3","author":"Waldman","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2022.109211_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-6386(87)80170-1","article-title":"The nephrotic syndrome and its complications","volume":"3","author":"Cameron","year":"1987","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clim.2022.109211_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ndt\/16.2.221","article-title":"Pathophysiology of acute renal failure in idiopatic nephrotic syndrome","volume":"2","author":"Koomans","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2022.109211_bb0105","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"9","author":"Murtas","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2022.109211_bb0110","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"85","author":"Fornoni","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2022.109211_bb0115","article-title":"Podocyte pathology and nephropathy - sphingolipids in glomerular diseases","volume":"127","author":"Merscher","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clim.2022.109211_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","article-title":"Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome","volume":"3","author":"Nakayama","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clim.2022.109211_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000167603","article-title":"Minimal-change glomerulopathy of adulthood","volume":"4","author":"Korbet","year":"1988","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.clim.2022.109211_bb0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/nep.12678","article-title":"Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single-centre study","volume":"10","author":"Komukai","year":"2016","journal-title":"Nephrology (Carlton)"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:07:53Z","timestamp":1761494873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622002923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"alternative-id":["S1521661622002923"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109211","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of rituximab for primary nephrotic syndrome with acute kidney injury: A two-center prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109211"}}